CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Sinclair IS Pharma PLC Company Snapshot
Business Description:
Sinclair IS Pharma PLC operates in the Pharmaceutical preparations sector. Sinclair IS Pharma PLC (Sinclair), formerly Sinclair Pharma plc, is an international specialty pharmaceutical company. The Company provides solutions to treat wounds, dermatological and oral diseases through surface technology and delivery systems. The Company operates in two segments: International Operations and Country Operations. Its areas in dermatology covers fungal infections, acne, atopic dermatitis and family dermatology. Its areas in wound care covers skin disinfection, radiation dermatitis treatment and wounds and burns healing. Its areas in oral care covers gingivitis, periodontitis, mouth ulcers and teething. Its dermatology products include Atopiclair, Bio-Taches, Papulex, Sebclair and Dermachronic. Its oral care products include Aloclair, Dermoxyl, Decapinol, Flammazine and Oxyplastine. In December 2010, the Company acquired Cranage Healthcare Limited. In December 2011, it acquired Advanced Bio-Technologies, Inc. In our complete report available for purchase the company is compared to: Allergy Therapeutics PLC, Vectura Group PLC and Alliance Pharma Plc.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sinclair IS Pharma PLC
  Stock Performance Chart for Sinclair IS Pharma PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (2/10/2012): 22.88p
(Figures in Pounds Sterling)
1 Week 4.6%   13 Weeks 0.5%  
4 Weeks -3.2%   52 Weeks -39.8%  
 
Sinclair IS Pharma PLC Key Data:
  Ticker: SPH Country: UNITED KINGDOM
  Exchanges: LON Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2011 Sales 32,897,000
(Year Ending Jan 2012).		 Employees: 101
  Currency: Pounds Sterling Market Cap: 87,110,926
  Fiscal Yr Ends: June Shares Outstanding: 380,812,790
  Share Type: Ordinary Closely Held Shares: 54,580,908
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.